TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/04/2025
Back to search
Official data from USPTO
VMRD VETERINARY MEDICAL RESEARCH & DEVELOPMENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
09/11/2025
Trademark type
Combined
Nice classes
5
Filing date
10/09/2012
Registration date
06/18/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/18/2025
Last transaction
09/11/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
10/04/2012
First use in commerce
10/04/2012
Drawing code
5
Owner type
03
Owner location
Pullman, WA
Examiner
CANTONE, KERI
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized letters "VMRD" with the words "Veterinary Medical Research & Development" directly below the stylized letters.
Holders and representatives
Holders
VMRD, Inc.
Representatives
Carrie Lofts Rainier Vista Law, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes
Publications
History of USPTO decisions and trademark events.
38 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/04/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/18/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/18/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/18/2025
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/18/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/18/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/17/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/17/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/17/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/17/2025
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
09/17/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/20/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/18/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/18/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/16/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/16/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/16/2019
E815
TEAS SECTION 8 & 15 RECEIVED
12/17/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/18/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2013
PUBO
PUBLISHED FOR OPPOSITION
04/02/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/25/2013
ALIE
ASSIGNED TO LIE
02/24/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
02/08/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/08/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
02/08/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/08/2013
DOCK
ASSIGNED TO EXAMINER
02/06/2013
MPMK
NOTICE OF PSEUDO MARK MAILED
10/16/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2012
NWAP
NEW APPLICATION ENTERED
10/12/2012
Continuous trademark protection
Get notified about every new filing that threatens VMRD VETERINARY MEDICAL RESEARCH & DEVELOPMENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.